May 20, 2024
Healthcare

Hearing Protection Devices in the U.S. is Expected to be Flourished by Growing Incidences of Hearing Loss

Karan Mukherjeeby Karan Mukherjee

Hearing protection devices such as earplugs and earmuffs are worn to prevent hearing damage from loud noises at work or recreationally. Earmuffs consist of an insulated and sometimes sound-deadening material contained in an adjustable or adjustable/disposable headband. Earmuffs fit over and around the ear and typically provide greater noise reduction than most earplugs. Earplugs attenuate sound by decreasing the sound pressure that reaches the eardrum. They come in disposable foam or reusable silicone types. The global hearing protection devices market plays a vital role in manufacturing hearing protection for laborers, industrial workers, construction workers, military personnel, and shooting range personnel, where hearing protection is mandated. It also provides devices for music enthusiasts and people flying or attending concerts.

 The U.S. hearing protection devices market is estimated to be valued at US$ 1.2 billion in 2023 and is expected to exhibit a CAGR of 10. % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
One of the key drivers for the hearing protection devices market in the U.S. is the growing incidences of hearing loss. According to the National Institute on Deafness and Other Communication Disorders (NIDCD), approximately 15% of American adults (37.5 million) aged 18 and over report some trouble hearing. Workplace noise is the most prevalent cause of hearing loss after age, affecting approximately 30 million U.S. workers. The noise exposure at workplaces like construction sites, manufacturing units, etc. requires employees to use hearing protection regularly. Federal standards by OSHA also mandate hearing conservation programs at job sites with noise levels over 85 decibels. As workplace noise regulations get stricter, demand for efficient hearing protection devices rises.

Segment Analysis
The U.S. hearing protection devices market is segmented into 1) Earplugs, 2) Earmuffs, 3) Uniform attenuation earplugs. Among these, earmuffs dominate the market and accounts for over 40% share owing to their effectiveness in providing protection against noise levels over 90 decibels. Earmuffs are affordable and comfortable to wear option available for various end-users from construction workers to military personnels.

PEST Analysis
Political: Stringent regulations such as Occupational Safety and Health Administration (OSHA) have mandated use of hearing protection for workers exposed to loud noise levels. This stimulates the demand.
Economic: Growing infrastructure and construction activities result in increased noise levels at workplaces driving use of such protective devices. Technological advancements have made devices affordable and comfortable.
Social: Increased focus on worker safety and productivity has led companies to ensure noise safe environments for employees. Health awareness about impact of noise on hearing has boosted adoption.
Technological: Manufacturers are focusing on offering smart, compact devices integrated with advanced noise cancelling mechanism and Bluetooth connectivity to enhance experience.

Key Takeaways
The U.S. hearing protection devices market size was valued over USD 500 million in 2023 and is expected to witness high growth.

The Midwestern region dominates the market and accounts for more than 30% share due strong presence of manufacturing and industrial sector generating noise. Key players operating in the U.S. hearing protection devices market are 3M, Honeywell International Inc., Amplifon., Starkey Hearing Technologies, Centurion Safety EU, ADCO Hearing Products Inc.

Regional analysis: The Midwestern region dominates the U.S. hearing protection devices market with largest share attributed to high presence of manufacturing, mining and industrial facilities operating without necessary precautions resulting in noise issues affecting workers. States including Illinois, Ohio, Michigan have stringent regulations in place requiring employers to ensure safe practices are followed.

Key players operating in the U.S. hearing protection devices market are 3M, Honeywell International Inc., Amplifon., Starkey Hearing Technologies, Centurion Safety EU, ADCO Hearing Products Inc. 3M is the market leader owing to its wide product portfolio and strong distribution network across the country.

*Note:

  1. Source: Coherent Market Insights, Public sources, Desk research

2. We have leveraged AI tools to mine information and compile it

Karan Mukherjee

View all posts by Karan Mukherjee →

You might also like

Alzheimer's Drugs Market

Alzheimer’s disease is a neurodegenerative disorder that currently affects an estimated 45 million people worldwide. As the global population ages, especially in developed economies, the prevalence of Alzheimer’s and other forms of dementia is rising significantly. By 2050, the number of people living with dementia worldwide is projected to triple and reach 152 million. The rising geriatric population, coupled with increased life expectancy, is the major driver of the global Alzheimer’s disease therapeutics market. Alzheimer’s drugs are medications that are used to slow down the progression of Alzheimer’s disease and relieve its symptoms. The most common Alzheimer’s drugs approved by regulatory agencies includeNamzaric, Exelon, Aricept, Razadyne, and Nuedexta. These drugs work by enhancing the neurotransmitter acetylcholine in the brain and by stabilizing levels of other neurotransmitters like dopamine and norepinephrine. As the disease progresses, these medications temporarily help cognitive functions like memory and thinking get better or stay the same for a limited period of time. The global Alzheimer’s Drugs Market is estimated to be valued at US$ 4.86 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the major trends witnessed in the global Alzheimer’s drugs market is the rising focus on combination therapy. Traditionally, monotherapies were the standard of care for Alzheimer’s disease. However, combination therapies targeting multiple pathways implicated in disease pathology are gaining favor. For instance, companies are evaluating drugs combining NMDA receptor antagonists with acetylcholinesterase inhibitors. Combination therapies hold promise to more effectively manage symptoms and potentially slow disease progression compared to single pathway targeting drugs. Ongoing research aims to establish combination therapies as a more efficacious treatment paradigm for Alzheimer’s disease. Porter’s Analysis Threat of new entrants: The threat of new entrants in the Alzheimer’s Drugs Market is moderate due to the need for extensive R&D and resources required for drug development. Bargaining power of buyers: The bargaining power of buyers is moderate due to the availability of substitute drugs and treatment options. Bargaining power of suppliers: The bargaining power of suppliers is moderate since there are many raw material suppliers available. Threat of new substitutes: The threat of new substitutes is high as research continues for better treatment options. Competitive rivalry: The competitive rivalry is high among existing players to develop new drugs with better efficacy and safety. Key Takeaways The global Alzheimer’s Drugs Market Share is expected to witness high growth over the forecast period of 2023 to 2030. Regional analysis reveals that North America currently dominates the market owing to high awareness and healthcare expenditure. Europe is also a major market boosted by supportive reimbursement policies. Asia Pacific is expected to be the fastest growing region on account of rising aging population and increasing healthcare spending. Key players operating in the Alzheimer’s Drugs market are AstraZeneca, GlaxoSmithKline plc, Pfizer Inc., Clovis Oncology, Inc., and Tesaro (acquired by GlaxoSmithKline). AstraZeneca’s drug BAN2401 and Pfizer Inc.’s drug aducanumab are some of the key pipeline products that are under development and have potential to capture significant market share. Collaborations between pharmaceutical companies and clinical research organizations are also expected to aid market growth over the forecast period.

Digital Biomarkers Market

Impact Of AI And Big Data Analytics To Power Digital Biomarkers Adoption To Assess Disease Risks And Progression Of Life Sciences Solutions

Healthcare CMO Market

Healthcare CMO Market to Witness High Growth Owing to Increasing Demand for Outsourcing Various Pharmaceutical Services